Arden Trust Co - ARROWHEAD PHARMACEUTICALS IN ownership

ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 315 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q4 2020. The put-call ratio across all filers is 0.54 and the average weighting 0.4%.

Quarter-by-quarter ownership
Arden Trust Co ownership history of ARROWHEAD PHARMACEUTICALS IN
ValueSharesWeighting
Q4 2020$324,000
+48.6%
4,211
-17.0%
0.05%
+38.5%
Q3 2020$218,000
-27.3%
5,075
-26.9%
0.04%
-29.1%
Q2 2020$300,000
+50.0%
6,9440.0%0.06%
+37.5%
Q1 2020$200,000
-55.6%
6,944
-2.0%
0.04%
-43.7%
Q4 2019$450,000
+123.9%
7,089
-0.8%
0.07%
+115.2%
Q3 2019$201,0007,1450.03%
Other shareholders
ARROWHEAD PHARMACEUTICALS IN shareholders Q4 2020
NameSharesValueWeighting ↓
WESTERN FINANCIAL Corp 820,346$62,945,00041.38%
Johnson & Johnson Innovation - JJDC, Inc. 3,260,869$250,206,00032.27%
Aquilo Capital Management, LLC 365,926$28,078,0005.84%
L1 Capital Pty Ltd 298,687$23,127,0004.32%
First Light Asset Management, LLC 704,449$54,052,0004.00%
ACUTA CAPITAL PARTNERS, LLC 139,000$10,665,0002.90%
Evolutionary Tree Capital Management, LLC 48,265$3,703,0002.82%
Parkman Healthcare Partners LLC 127,171$9,758,0002.50%
Capital Impact Advisors, LLC 88,183$6,766,0001.66%
Tri Locum Partners LP 56,003$4,297,0001.56%
View complete list of ARROWHEAD PHARMACEUTICALS IN shareholders